Why You Can’t Ignore The Growing Antibiotic Market

 Feb 17, 2012 |

 

Scientists are very interested in bacteria for a number of reasons. Among the most recent is that they can be used to manufacture various important chemicals, including fuels.

We tend not to think about it, but the single-cell microorganisms categorized as bacteria are the dominant life form on Earth. In some mathematical sense, this is their planet and we just use it.

Their total biomass, after all, is greater than that of all living plants and animals combined. Bacteria inhabit the planet from the highest peaks to the deepest depths of the ocean. There are typically 40 million bacteria in one gram of soil and a million in a milliliter of fresh water. In our bodies, bacteria outnumber human cells 10 to one.

Besides making extremely useful things possible, including Rioja wines, single-malt scotches and the Earth's biosphere, bacteria can also cause serious problems. Bacterial infection, in fact, may be the single largest killer in America today.

However, we don't hear about a bacterial plague for several reasons…

One is that some pre-existing conditions, such as diabetes or a virus-borne disease, often create the conditions that lead to an opportunistic bacterial infection. So statisticians tend to categorize deaths according to the condition that led to the lethal infection that actually killed the patient.

Also, I suspect that the medical profession doesn't like to talk about the danger of infections that are often acquired in hospitals, though I may be too cynical.

Regardless, some estimates are that bacteria cause, in the U.S. alone, over 14 million skin and soft tissue infections, and 7 million methicillin-resistant Staphylococcus aureus (MRSA) cases, annually. Of those infections, 70% are resistant to at least one antibiotic.

Moreover, resistance is growing due to natural evolutionary mechanisms as well as the misuse and overprescription of antibiotics.

Just a few weeks ago, the world medical community suffered a serious scare when an Indian clinic announced it had a dozen patients with highly contagious tuberculosis resistant to all known antibiotics. A totally untreatable TB could, in fact, easily kill hundreds of millions and send Western economies into a long depression.

Fortunately, the announcement was false. A therapy was found and the epidemic prevented.

Still, the trend lines are clear, and public perception of this threat is growing.

There are companies, however, that continue to make serious progress in the goal of creating new and effective antibiotics that bacteria could not adapt to.

With a $10 billion market that is rapidly growing, the potential rewards are stratospheric. Investors would be wise to pay attention to companies working to create new effective antibiotics…

As concern over the fading effectiveness of antibiotics grows, investor attention will turn to the few companies working on solutions. Now is the time to act… before everyone else does.



Follow iStockAnalyst on Twitter Follow iStockAnalyst on Twitter

Subscribe to Email Alerts rss feed or RSS feeds rss feed

Comments Closed


  
Advertisement
Popular Articles
Recent Research and Quote
Advertisement
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.